Abstract BACKGROUND Cardiac troponins I (cTnI) and T (cTnT) have received international
endorsement as the standard biomarkers for detection of myocardial injury, for risk …

The 2021 American Heart Association/American College of Cardiology/American Society of
Echocardiography/American College of Chest Physicians/Society for Academic Emergency …

Recommendations for the use of cardiac troponin (cTn) measurement in acute cardiac care
have recently been published. 1 Subsequently, a high-sensitivity (hs) cTn T assay was …

BACKGROUND Between-assay comparability of 99th percentiles for cardiac troponin
concentrations has not been assessed systematically in a single population for a large …

Context.—A relevant portion of coronavirus disease 2019 (COVID-19) patients develop
severe disease with negative outcomes. Several biomarkers have been proposed to predict …

Objectives: The study sought to determine the 99th percentile upper reference limit for the
high-sensitivity cardiac troponin T assay (hs-cTnT) in 3 large independent cohorts …

Troponin is a widely used biomarker in patients with cardiac disease. The use of troponin is
well established in patients with suspected acute myocardial infarction (AMI), but troponin …

The National Academy of Clinical Biochemistry issued a guideline in 2007 that stated that “in
the presence of a clinical history suggestive of ACS, the following is considered indicative of …

Over the past 2 decades, cardiac troponins (cTn) have emerged as the preferred biomarkers
for the noninvasive detection of myocardial injury. In conjunction with typical clinical findings …

Background: Cardiac troponins (cTns) are the cornerstone of diagnosing acute myocardial
infarction. There is limited knowledge on the duration of ischemia necessary to induce a …